2023
DOI: 10.1016/j.neuron.2023.02.020
|View full text |Cite
|
Sign up to set email alerts
|

Choroid plexus-targeted NKCC1 overexpression to treat post-hemorrhagic hydrocephalus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

2
27
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 25 publications
(30 citation statements)
references
References 85 publications
2
27
1
Order By: Relevance
“…The latter can be therefore considered an estimation of the maximum amount of water molecules transported per alternating access cycle. Interestingly, these semiquantitative observation enrich the current experimental evidence for water transport by NKCC1 , and its functional implications in the context of CSF accumulation recently demonstrated. , Indeed, water may cross the membrane via the formation of permeable states, as has been reported for a wide range of transporters, including Na + /glucose transporter (SGLT), glutamate transporter (Glt ph ), glycerol-3-phosphate transporter (GlpT), sodium-benzylhydantoin transporter (Mhp1), and the maltose transporter, and more recently also shown for the sodium/proton antiporter PaNhaP …”
Section: Discussionsupporting
confidence: 76%
See 1 more Smart Citation
“…The latter can be therefore considered an estimation of the maximum amount of water molecules transported per alternating access cycle. Interestingly, these semiquantitative observation enrich the current experimental evidence for water transport by NKCC1 , and its functional implications in the context of CSF accumulation recently demonstrated. , Indeed, water may cross the membrane via the formation of permeable states, as has been reported for a wide range of transporters, including Na + /glucose transporter (SGLT), glutamate transporter (Glt ph ), glycerol-3-phosphate transporter (GlpT), sodium-benzylhydantoin transporter (Mhp1), and the maltose transporter, and more recently also shown for the sodium/proton antiporter PaNhaP …”
Section: Discussionsupporting
confidence: 76%
“…Interestingly, these semiquantitative observation enrich the current experimental evidence for water transport by NKCC1 31,32 and its functional implications in the context of CSF accumulation recently demonstrated. 33,34 Indeed, water may cross the membrane via the formation of permeable states, as has been reported for a wide range of transporters, including Na + /glucose transporter (SGLT), glutamate transporter (Glt ph ), glycerol-3-phosphate transporter (GlpT), sodium-benzylhydantoin transporter (Mhp1), and the maltose transporter, 35 and more recently also shown for the sodium/proton antiporter PaNhaP. 36 One more mechanistic feature from our simulations is the interhelical interface intrinsically associated with NKCC1's transport capabilities.…”
Section: ■ Discussionmentioning
confidence: 99%
“…Activation of microglial nucleotide-binding and oligomerization domain-like receptors can be triggered by inflammation-induced tissue damage of CNS barrier epithelia (the CP epithelia and ependyma) and associated damage-associated molecular pattern molecule release, which could propagate and sustain the neuroinflammatory reaction in the CP 28,29 . In addition, the bidirectional Na-K-Cl cotransporter (ie, NKCC1) plays a key role in CP to mitigate hydrocephalus, but bumetanide, a NKCC1 inhibitor, and its derivatives show a low level of CNS penetration indicating that it might not always be effective 27,30,31 . Therefore, Karimy et al 5 proposed that targeting inflammation as opposed to CP epithelia ion transport is a particularly promising therapeutic approach for hydrocephalus; that is, beyond driving the initial CSF hypersecretory response, inflammation is likely to contribute to the ensuing tissue damage and release of damage-associated molecular pattern that ultimately leads to sustained hydrocephalus.…”
Section: Discussionmentioning
confidence: 99%
“…28,29 In addition, the bidirectional Na-K-Cl cotransporter (ie, NKCC1) plays a key role in CP to mitigate hydrocephalus, but bumetanide, a NKCC1 inhibitor, and its derivatives show a low level of CNS penetration indicating that it might not always be effective. 27,30,31 Therefore, Karimy et al 5 proposed that targeting inflammation as opposed to CP epithelia ion transport is a particularly promising therapeutic approach for hydrocephalus; that is, beyond driving the initial CSF hypersecretory response, inflammation is likely to contribute to the ensuing tissue damage and release of damage-associated molecular pattern that ultimately leads to sustained hydrocephalus.…”
Section: Discussionmentioning
confidence: 99%
“…Developing specific genetic tools to manipulate the ChP in a time-specific manner is a game changer. It has been so far very difficult to specifically target the ChP using genetics, and often researchers have made use of the AAV2/5 serotype which preferentially target the ChP epithelial cells in rodents (Chen et al , 2020; Haddad et al , 2013; Jang & Lehtinen, 2022; Sadegh et al , 2023; Xu et al , 2021). Here we generated a versatile genetic tool using the Gal4-UAS system allowing for the first time to specifically investigate and manipulate the ChP epithelial cells in the zebrafish.…”
Section: Discussionmentioning
confidence: 99%